USPTO Assignments on the Web

	United States Patent and Trademark Office
	Home\|Site Index\|Search\|Guides\|Contacts\|eBusiness\|eBiz alerts\|News\|Help

Assignments on the Web > Patent Query

Patent Assignment Assignor Details

NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Assignor Name : BRIDGEBIO GENE THERAPY RESEARCH, INC.

Total Assignments: 3

Assignment: 1

Reel/Frame:	066342/0154			Pages:	26
		Recorded:	01/17/2024
Attorney Dkt #:	347580-104
Conveyance:	SECURITY INTEREST (SEE DOCUMENT FOR DETAILS).

Assignors

1

CALCILYTIX THERAPEUTICS INC.

Exec Dt:

01/17/2024

2

ADRENAS THERAPEUTICS INC.

Exec Dt:

01/17/2024

3

PHOENIX TISSUE REPAIR, INC.

Exec Dt:

01/17/2024

4

NAVIRE PHARMA, INC.

Exec Dt:

01/17/2024

5

Exec Dt:

01/17/2024

6

MOLECULAR SKIN THERAPEUTICS, INC.

Exec Dt:

01/17/2024

7

CANTERO THERAPEUTICS, INC.

Exec Dt:

01/17/2024

8

COA THERAPEUTICS, INC.

Exec Dt:

01/17/2024

9

PORTAL THERAPEUTICS, INC.

Exec Dt:

01/17/2024

10

BRIDGEBIO GENE THERAPY RESEARCH, INC.

Exec Dt:

01/17/2024

11

FERRO THERAPEUTICS, INC.

Exec Dt:

01/17/2024

12

Exec Dt:

01/17/2024

Assignee

1

BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT

399 PARK AVENUE, 37TH FLOOR

NEW YORK, NEW YORK 10022

Properties

	Pat #	Pub #	Intl #	App #		Pat #	Pub #	Intl #	App #		Pat #	Pub #	Intl #	App #
	9676837	US20150011733		14236403		9733263	US20160011219		14440958		10921332	US20180011118		15646303
	10513497	US20180237396		15932327		10695395	US20190000912		16065512		10669327	US20190077845		16084998
	11098040	US20190263802		16287805		11058668	US20190290616		16361587		10954243	US20190389867		16401047
	11104675	US20200048249		16536923		11260047	US20200054607		16542737		11078162	US20200247756		16676931
	11661429	US20200247816		16783050		11040964	US20200299283		16803862		11547709	US20210023081		16957996
	11891378	US20210061788		16958022		NONE	US20210277365		16962552		11643420	US20210101911		17037910
	NONE	US20210132091		17141586		11932643	US20210317122		17166737		11401246	US20210403439		17255600
	12070449	US20220016081		17332359		11919865	US20220041558		17350066		11945815	US20220041594		17380943
	NONE	US20220040193		17393196		NONE	US20220087961		17477198		12005043	US20220313661		17577479
	NONE	US20220177546		17598029		NONE	US20220233536		17613651		NONE	US20220233537		17613652
	NONE	US20220227716		17638741		NONE	US20220227765		17638744		NONE	US20220291236		17679841
	NONE	US20230129160		17791482		NONE	US20230143491		17843455		NONE	US20240092739		18023270
	NONE	US20230321092		18076044		NONE	US20230414698		18169368		NONE	US20240074978		18216536
	NONE	US20240009193		18257450		NONE	US20240067658		18295009		NONE	US20230416269		18297698
	NONE	US20240002812		18319350		NONE	US20240246954		18546317		NONE	US20240191213		18551143

Correspondence name and address
	COOLEY LLP
	3 EMBARCADERO CENTER, 20TH FLOOR
	SAN FRANCISCO, CA 94111

Assignment: 2

Reel/Frame:	066355/0126			Pages:	29
		Recorded:	01/19/2024
Attorney Dkt #:	347580.104
Conveyance:	SECURITY INTEREST (SEE DOCUMENT FOR DETAILS).

Assignors

1

BRIDGEBIO PHARMA, INC.

Exec Dt:

01/17/2024

2

QED THERAPEUTICS, INC.

Exec Dt:

01/17/2024

3

EIDOS THERAPEUTICS, INC.

Exec Dt:

01/17/2024

4

Exec Dt:

01/17/2024

5

ML BIO SOLUTIONS INC.

Exec Dt:

01/17/2024

6

CALCILYTIX THERAPEUTICS INC.

Exec Dt:

01/17/2024

7

ADRENAS THERAPEUTICS INC.

Exec Dt:

01/17/2024

8

PHOENIX TISSUE REPAIR, INC.

Exec Dt:

01/17/2024

9

NAVIRE PHARMA, INC.

Exec Dt:

01/17/2024

10

Exec Dt:

01/17/2024

11

MOLECULAR SKIN THERAPEUTICS, INC.

Exec Dt:

01/17/2024

12

CANTERO THERAPEUTICS, INC.

Exec Dt:

01/17/2024

13

COA THERAPEUTICS, INC.

Exec Dt:

01/17/2024

14

PORTAL THERAPEUTICS, INC.

Exec Dt:

01/17/2024

15

BRIDGEBIO GENE THERAPY RESEARCH, INC.

Exec Dt:

01/17/2024

16

FERRO THERAPEUTICS, INC.

Exec Dt:

01/17/2024

17

Exec Dt:

01/17/2024

Assignee

1

BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT

399 PARK AVENUE, 37TH FLOOR

NEW YORK, NEW YORK 10022

Properties

	Pat #	Pub #	Intl #	App #		Pat #	Pub #	Intl #	App #		Pat #	Pub #	Intl #	App #
	9676837	US20150011733		14236403		9733263	US20160011219		14440958		10921332	US20180011118		15646303
	10513497	US20180237396		15932327		10695395	US20190000912		16065512		10669327	US20190077845		16084998
	11098040	US20190263802		16287805		11058668	US20190290616		16361587		10954243	US20190389867		16401047
	11104675	US20200048249		16536923		11260047	US20200054607		16542737		11078162	US20200247756		16676931
	11661429	US20200247816		16783050		11040964	US20200299283		16803862		11547709	US20210023081		16957996
	11891378	US20210061788		16958022		NONE	US20210277365		16962552		11643420	US20210101911		17037910
	NONE	US20210132091		17141586		11932643	US20210317122		17166737		11401246	US20210403439		17255600
	12070449	US20220016081		17332359		11919865	US20220041558		17350066		11945815	US20220041594		17380943
	NONE	US20220040193		17393196		NONE	US20220087961		17477198		12005043	US20220313661		17577479
	NONE	US20220177546		17598029		NONE	US20220233536		17613651		NONE	US20220233537		17613652
	NONE	US20220227716		17638741		NONE	US20220227765		17638744		NONE	US20220291236		17679841
	NONE	US20230129160		17791482		NONE	US20230143491		17843455		NONE	US20240092739		18023270
	NONE	US20230321092		18076044		NONE	US20230414698		18169368		NONE	US20240074978		18216536
	NONE	US20240009193		18257450		NONE	US20240067658		18295009		NONE	US20230416269		18297698
	NONE	US20240002812		18319350		NONE	US20240246954		18546317		NONE	US20240191213		18551143

Correspondence name and address
	COOLEY LLP
	3 EMBARCADERO CENTER, 20TH FLOOR
	SAN FRANCISCO, CA 94111

Assignment: 3

Reel/Frame:	067870/0874			Pages:	11
		Recorded:	06/28/2024
Attorney Dkt #:	347580-104
Conveyance:	SECURITY INTEREST (SEE DOCUMENT FOR DETAILS).

Assignors

1

BRIDGEBIO PHARMA, INC.

Exec Dt:

06/18/2024

2

EIDOS THERAPEUTICS, INC.

Exec Dt:

06/18/2024

3

ML BIO SOLUTIONS INC.

Exec Dt:

06/18/2024

4

NAVIRE PHARMA, INC.

Exec Dt:

06/18/2024

5

FERRO THERAPUETICS, INC.

Exec Dt:

06/18/2024

6

QED THERAPEUTICS, INC.

Exec Dt:

06/18/2024

7

BRIDGEBIO GENE THERAPY RESEARCH, INC.

Exec Dt:

06/18/2024

8

BRIDGEBIO SERVICES INC.

Exec Dt:

06/18/2024

9

CANTERO THERAPEUTICS, INC.

Exec Dt:

06/18/2024

Assignee

1

BLUE OWL CAPITAL CORPORATION

399 PARK AVENUE, 37TH FLOOR

NEW YORK, NEW YORK 10022

Properties

Pat #

Pub #

Intl #

App #

Pat #

Pub #

Intl #

App #

NONE

18413175

NONE

18570040

Correspondence name and address
	JENNIFER GU
	3175 HANOVER STREET
	PALO ALTO, CA 94304-1130

Search Results as of: 11/10/2024 02:43 PM

If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6

Web interface last modified: August 25, 2017 v.2.6

| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT